Protecting Animal Health. Serban Morosan, DVM, PhD, Dip. Vet LAS UMS 28 phenotype du petit animal Faculty of Medicine Pierre et Marie Curie, Paris

Size: px
Start display at page:

Download "Protecting Animal Health. Serban Morosan, DVM, PhD, Dip. Vet LAS UMS 28 phenotype du petit animal Faculty of Medicine Pierre et Marie Curie, Paris"

Transcription

1 Protecting Animal Health Serban Morosan, DVM, PhD, Dip. Vet LAS UMS 28 phenotype du petit animal Faculty of Medicine Pierre et Marie Curie, Paris 1

2 Topics Health, health status & exclusion list Developing an exclusion list Health Monitoring Protecting the health status of your mice Introducing mice into the colony Barriers Animal care Researchers Precaution during research 2

3 Healthy Mouse What is a Healthy Mouse? 3

4 Mouse Health vs. Health Statuts Healthy mouse : No signs of disease; exhibiting normal behavior Many pathogens do not cause clinical disease Health status : microbial status, usually of the colony Defined in terms of specific : Pathogenic viruses, bacteria, fungi, etc. Parasites Opportunistic pathogens 4

5 Definitions Pathogen : an infectious agent that can cause overt disease and/or alter biologic response(s) during experimentation An organism need not cause disease to be undesirable Opportunist : en infectious agent that is not normally pathogenic but that may cause disease or alter biologic responses under certain circumstances (e.g;, sick/injured or immunodeficient mouse) Commensal : an organism that inhabits and derives benefit from a host without either benefiting or harming the host Zoonotic : transmissible from animals to human Reverse zoonotic : transmissible from human to animals 5

6 A Spectrum of Harmful Potential 6

7 Exclusion list A list of organisms that you will not tolerate in your animal colony facility Defines the desired health status of your mice Basis for making good decisions regarding : Handling of news additions to the colony, e.g., quarantine procedures Standard operating procedures Animal care Research What should be on it? Depends on the needs of your program 7

8 Developing An Exclusion List for Your Program or Facility 8

9 Animal facilities and Budget Program Needs Motivation Exclusion List 9

10 Health Status What do you want? What do you need? What can you maintain? 10

11 Possible Impact on Research Infectious agents may affect breeding performance Disruption in physiology may cause anomalous results even if mice appear healthy: MPV : alteration of CD4+ and CD8 T cells mediated responses; accelerated rejection of tumor and skin allografts; altered tumor development; Inhibition of diabetic phenotype in NOD by many agents, inclusive MHV, LCMV, pinworms, mycobacterium. Pinworm : stimulate mucosal immunity; may induce or accelerate lymphoma development in nude mice 11

12 Host factors may Be Critical Age, stress, immune status Strain and specific genetic modifications: Mice lacking intact interferon signaling pathways due to a lack of type I and/or type II IFN receptors or STAT-1 molecule lethal MNV infection C3H/HeJ (homozygous for the defective LPS response allele Tlr4 Lps-d & Tlr4 knockouts Gram negative infections 12

13 Other considerations Zoonotic potential Collaborations Your health monitoring capabilities/budget Your ability to : Adhere to exclusionary measures Act in the event of a break 13

14 Commonly Excluded Pathogenic viruses, Mycoplasma/pathogenic bacteria: All alter normal physiology Most can affect breeding productivity Some cause illness +/- death Parasites : Stressors that alter normal physiology May affect clinical health and/or breeding All may limit ability to share mice with collaborators 14

15 Some Opportunist to Consider Mouse adapted organism : Mouse norovirus Pneumocystis murina Helicobacter Pasteurella Corynebacterium Human commensals/environmental contaminants : Staphylococcus Pseudomonas B hemolytic Streptococcus Klebsiella Escherichia coli 15

16 Health monitoring program A health monitoring program is designed to : Assure the health and well-being of our animal colonies by routine and extensive monitoring for undesirable agents Prevent the entry of infectious agents by rederivation and strict health monitoring of all incoming mice Minimize the opportunity for transmission of infectious agents between cages (specific housing equipment and rigorous animal health practices) 16

17 Health monitoring program A health monitoring program provide information about: Prevalence rates of infectious agents Microbiological status of laboratory animals Continuous reporting of prevalence rates on regular basis is important : For the design of a cost effective health monitoring program For the interpretation of diagnostic test results For an update of standard health monitoring recommendation (such as FELASA) 17

18 Health monitoring program Purpose is to find at least one infected animal if an organism from your exclusion list is present in the colony Elements of a health monitoring strategy Frequency of monitoring Number and distribution of animal for testing Age, sex and immunological status of animals Colony animals vs sentinels Testing methods 18

19 Health monitoring program Purpose is to find at least one infected animals if a organism from your exclusion list is present in the colony Elements of a health monitoring strategy Frequency of monitoring Number and distribution of animals for testing Age, sex and immunologic statute of animals Colony animals vs. sentinels Testing methods 19

20 Which Animals to Test Colony animals random selection, but all strains Sentinels : 6 wk generally best Younger animals best for parasitology Test animals from all strains/investigators Sentinels strain can make the difference Choose CD1, Swiss, NMRI, Balb/c, C 3 H or DBA over C 57 BL/6 Immunodeficient good for direct test (PCR, culture); useless for serology 20

21 Sentinels Dirty bedding Poor transmission of some organisms: Organism not spread by fecal oral route, e.g. Sendai virus Labile organism, e.g., MHV, Pasteurella Suboptimal exposure to infectious agent : delayed detection, e.g. MPV, MNV Sentinels don t share history with colony animals (shipping, research manipulation) Contaminated sentinel False indicator of colony health May introduce contaminants 21

22 Sentinels Recommendations Don t rely exclusively on dirty bedding sentinels (DB) Supplement with colony animals and/or contact sentinels DB sentinels can improve coverage at lower cost Improve results with DB sentinels Small ratio of colony cages per sentinel Allow at least 1 month exposure, preferably 2-3 Make sure that sentinels are clean prior to placement 22

23 Sample Size Inverse ratio between prevalence and # tested Prevalence = percentage of animals in the colony that are infected Most commonly aim for detection at 50% prevalence Can calculate mathematically Formulas assume random spread and random sampling When assumptions don t hold 1 cage of DB sentinels per colony cages Lower ratio better if relying exclusively on sentinels 5-16 colony animals/contact sentinels per room 23

24 Factors Affecting Prevalence Latency to reach a certain prevalence after introduction of the contaminant will vary with: The organism, especially in epizootic contaminations Shorter with rapidly spreading organisms (e.g., MHV) than those that spread more slowly (e.g., Helicobacter) Caging system microisolater/ivc caging will slow spread Animal handling SOPs Strict microisolator technique can prevent spread 24

25 Monitoring Frequency Test more frequently for the organisms of greatest concern, e.g., MHV, MPV Test less frequently for organisms of less concern, e.g., K virus, Polyoma virus Highest frequency for special cases, e.g., Organism present in one part of the facility, excluded from another Recovering from a break Highly protected colony, e.g., sentinel or foster mother colony 25

26 Testing Methods Serology Sensitive, specific, cost effective methods for detection of most viruses, Mycoplasma, some bacteria False positives can occur, esp. with tests for complex organism and with tests of lower specificity Nonspecific tests can occur, esp. with older animals or animals prone to autoimmune disease Retest suspicious MFI positives with ELISA or IFA 26

27 Testing Methods PCR Advantages Extraordinary sensitivity Potentially applicable for detection of viruses, parasites, bacteria, fungi Disadvantages False negatives Wrong tissue sampled Infected animal sampled at wrong time Reaction inhibitors in some tissues False positives Easily contaminated Easily misinterpreted 27

28 Serology vs. PCR Virus Antibodies Virus Titer Anti-body Titer Latent Period Virus Exposure Seroconversion 28

29 Pathogen Time after onset of infection in weeks >12 MVM MPV MHV MNV PVM Sendai TEMV intermittent spread possible EDIM consistent viral shedding possible Reo3 Ectromelia Clostridium piliforme Mycoplasma pulmonis Adenovirus-2 LCMV KRV Toolan H1 RPV RCV / SDA Pathogens as listed above Presence of antibodies in immune competent animals: serology Pathogen Time after onset of infection in weeks >12 Helicobacter spp. Pasteurella pneumotropica Syphacia spp. Aspiculuris tetraptera

30 PCR on feces What is the chance of detecting pathogens by PCR? Sample of choice: Feces Pathogen: 1. Helicobacter 2. MNV (Murine Norovirus) 3. Pasteurellaceae 4. MHV (Mouse Hepatitis Virus) 5. Sendai / PVM (Pneumonia Virus of Mice)

31 Chance of success depends on: 1. Prevalence (occurrence) of infection 2. Prevalence (spread) within animal colony 3. Period of shedding pathogen 4. Optimal sampling site

32 PCR on feces What is the chance of detecting Helicobacter by PCR? Absent Present

33 PCR on feces What is the chance of detecting Helicobacter by PCR? Absent 20% Present 80%

34 Chance of success for Helicobacter: 1. Prevalence (occurrence) of infection High 2. Prevalence (spread) within animal colony High 3. Period of shedding pathogen Long term 4. Optimal sampling site Feces / coecum contents Other diagnostic techniques?

35 PCR on feces What is the chance of detecting Pasteurellaceae by PCR? Absent Present

36 PCR on feces What is the chance of detecting Pasteurellaceae by PCR? Absent 70% Present 30%

37 Chance of success for Pasteurellaceae: 1. Prevalence (occurrence) of infection High 2. Prevalence (spread) within animal colony High 3. Period of shedding pathogen No shedding of viable bacteria in feces 4. Optimal sampling site Oral swab Other diagnostic techniques?

38 PCR on feces What is the chance of detecting MNV by PCR? Absent Present

39 PCR on feces What is the chance of detecting MNV by PCR? Absent 40% Present 60%

40 Chance of success for MNV: 1. Prevalence (occurrence) of infection High 2. Prevalence (spread) within animal colony High 3. Period of shedding pathogen Long term 4. Optimal sampling site Feces / coecum contents Other diagnostic techniques?

41 PCR on feces What is the chance of detecting MHV by PCR? Absent Present

42 PCR on feces What is the chance of detecting MHV by PCR? Absent 50% - 100% Present 0% - 50%

43 Chance of success for MHV: 1. Prevalence (occurrence) of infection High 2. Prevalence (spread) within animal colony High 3. Period of shedding pathogen Short term! 4. Optimal sampling site Feces only during shedding Blood; antibody detection Other diagnostic techniques?

44 Chance of success for MHV: 3. Period of shedding pathogen Short term! 4. Optimal sampling site Feces only during shedding. Blood; antibody detection MHV infected mouse animal 1 Time after onset of infection in weeks >12 animal 2 animal 3 animal 4 animal 5 animal 6 animal 7 animal 8 animal 9 animal 10 chance in % Spread of infection through feces Presence of antibodies in immune competent animals

45 PCR on feces What is the chance of detecting Sendai / PVM by PCR? Absent Present

46 PCR on feces What is the chance of detecting Sendai / PVM by PCR? Absent 100% Present 0%

47 Chance of success for Sendai / PVM: 1. Prevalence (occurrence) of infection Low 2. Prevalence (spread) within animal colony High 3. Period of shedding pathogen Not through feces 4. Optimal sampling site Blood; antibody detection Other diagnostic techniques?

48 Is PCR the solution? Advantages Non invasive (feces) Sensitive Fast (compared to waiting time antibody response) Pooling of samples possible Identification of new pathogens (general PCR s) Disadvantages Non invasive sample site not always the best sample site Time window (spread of infection) No discrimination between viable / non viable pathogen More expensive than serology / culture Species specific PCR s narrows the window of screening Complete FELASA panel not possible

49 Is PCR the solution? PCR Yes PCR No Live saving sampling (Vivum) Import check Pathogens which are difficult to culture Follow up after proven infection When complete FELASA panel is needed Active infection (no discrimination viable / nonviable agents) Short term shedding of pathogens When sample required for PCR is suboptimal Biological samples Environmental check (?)

50 Other Methods Microbiologic culture - method of choice for most bacteria and fungi Difficult or impossible to cultivate some organisms Suppression of growth by competing organisms Parasitology fecal flotation, direct microscopy, examination of skin or pelage, cellophane tape Gross and histopathology can suggest most likely etiology of disease for further investigation; can be used to confirm diagnosis 50

51 Positive Finding? Single positive result may not mean anything! Retest by same and other test methods If first animal confirmed positive test additional animals Interpret based on all test results and experience If results are confirmed and make sense... Time to implement your action plan! 51

52 Protecting Mouse Health Introduction of new animals Housing and husbandry Use in research 52

53 Receipt Check shipping box for integrity Thoroughly disinfect the outside of the box Briefly check each mouse as it s unpacked 53

54 Introduction News animals (Three Options) Send to colony room Quarantine Rederive Greatest risk Least risk Least expensive Most expensive 54

55 Pros Cons Send to room Immediate access Greatest risk to colony; no built in acclimatation Quarantaine Reduced risk for colony Delayed access; space &cost Rederive Least risk to colony eliminate future pathogens Delayed access; space &cost Recommend 3-5 days Benefit depends on procedures & testing 55

56 Quarantaine Principles Physically separate from established colonies Separate animals by source (& shipment if possible) Dedicated caretakers, caretakers who care 1º for nonrodents, or end of day Handle latest arrivals last At least 3 wk; longer better Test before release 56

57 Rederivation Newborn fostering most risky Hysterectomy derivation long history of proven effectiveness with most pathogens Embryo transfer / in vitro fertilization faster; effectiveness depends on thorough washing Ovarian transplantation : Unlikely to be effective with all organisms 57

58 Levels of Protection Conventional Low barrier High barrier Isolator Risk Cost/incovenience Risk Cost/incovenience 58

59 Barriers and animal Health Barrier separates/isolates the animal from the surrounding environment Prevents introduction +/- spread of unwanted infectious agents Levels (and effectiveness) vary from maximum to minimum Barrier may be at the cage or at the room/facility Both physical and operational elements Adherence to well-designed procedures is crucial to success 59

60 Facility/Room Level Barrier 1 focus on preventing introduction of contaminants Exclude wild rodents Air pressure differentials (usually + vs. corridor) HEPA-filtered air Animals in open caging, changed on open tables May also utilize cage-level barrier to prevent spread 60

61 Barrier Procedures Maximun Barrier Rederive mice Shower (wet or air) Sterilize water, e.g. RO, UV, filtered, acidified, chlorinated Low Barrier Quarantine mice Lab coat or gown + shoe covers Tap water Cap, mask, gloves, restricted entery 61

62 Cage Level Barrier Isolates individual cages (microisolater, IVC) Prevents introduction and spread of contaminants Emphasis on procedures 62

63 IVC Technique Sterilize all materials contacting mice No cages opened outside of change station All materials entering change station sterilized or cleaned with high-level disinfectant Gloved hands frequently disinfected Sleeve guards increase protection Handle mice with disinfected forceps Avoid touching materials that will come into direct contact with mice, e.g., inside of cage 63

64 Isolators Can be viewed as very small maximum barrier rooms Sterilize all materials entering isolator Disinfection of ports before introduction or removal of materials is critical 64

65 What Level of Barrier Is Needed? Exclude only rodent-adapted pathogens or opportunists? 1 focus on preventing: introduction of contaminants via mice or tissues spread of contaminants from one colony to another Exclude opportunists that are widespread in environment or carried by humans? Additional focus on materials, people, air, water At least high barrier maximum or isolator better for long term success 65

66 Animal Care Dedicated caretakers if possible Handle higher health status before lower Caretaker training critical Your operation is only as good as your caretakers! 66

67 Care during experimental use as important as husbandry! 67

68 Research In Barrier Facilities Folow all barrier procedures Ventilated changing station/hoods whenever possible One-way trips best Need to use shared resources (e.g. irradiateurs, phenotyping equipment) or remove animals from barrier ( e.g. lab)? 68

69 News Technological Developments in Health Monitoring of rodent colonies Serban Morosan, DVM, PhD, Dip. Vet LAS UMS 28 phenotype du petit animal Faculty of Medicine Pierre et Marie Curie, Paris 69

70 Maintaining an SPF Facility Depend on Realiable screening of incoming biological materials and animals Maintain o good biesecurity program Reliable health monitoring of resident animal to detect problems and to certify SPF status Monitor key prosesses such as autoclaving, e.g 70

71 Biological Microbial contamination Mycoplasma Viruses Bacteria &fungi Biological : - Cell lines - Serum - Antibody - Material archived in freezers 8-10 % are contaminated with Mycoplasma 2% are contaninated with a human or rodent pathogen 6% of cell lines contaminated with slow-growing bacteria or fungi ATCC: The Global Bioresource Center 71

72 Questions to determine if incoming animals threaten the facility Are you positive? Are you infective? 72

73 Incoming animals (if quarantine) Time : 6-8 weeks after arrival Sample(s) : live mice (1-2 per shipment) Protocol(s) : HM complete ( results in 1-2 we) Final time : 8-10 weeks 73

74 Incoming animals (if quarantine) Test by mouse line few days post-arrival 1. Faecal Pellets : a faecal pellet from each rodent 2. Oral Swabs : respiratory agents 3. Skin Swabs : C. bovis and ectoparasites Time : 2-3 day Sample(s) : samples (pooled) from up to 10 mice Protocol(s) : PCR ( results in 1-2 we) Final time : 2-3 weeks 74

75 Incoming animals (if quarantine) Bact Fungi Respiratory Skin Enteric Oral Swab Skin swab Feces Viruses Enteric Feces Parasites All Pinworms and Protozoa Ectoparasites Serum Feces Pelt/cage Swab 75

76 Optimal quarantine Criteria for Testing Program (example) 1. Exclusion list ( identifies all pathogens on your exclusion list) Detect organism that are being shed, e.g. pinworms Detects antibodies to current and past infections, e.g. MPV Detects organism that are not readily transmitted to sentinels, e.g. Pasteurella, Helicobacter 2. Minimizes quarantine time Animals are tested directly No need to wait for sentinels to become infected or seroconvert Time : 2-3 weeks 3. Minimizes costs No sentinels 76

77 Questions associated with sentinel screening 1. The infection is transmitted to the sentinel cage? 1. Biological materiel is enough to infect the sentinel? 1. Is the sentinel receptive ( line, age..) 1. Is the exposure long enough? 1. What do you do if you have a positive result? 77

78 Variables associated with sentinel screening 1. Infected animal may not be shedding substantial doses of the agent 2. Frequency and amount of bedding transferred to the sentinel cages 3. Some agents may not survive well outside of the host e.g. enveloped virus, helicobacter 4. The age and strain of sentinel animal can impact susceptibility 78

79 Infectious agents and IVC 1. Agent that are likely to reach the sentinel cage 2. Agent that are likely to reach the sentinel cage but lose infectivity 3. Agents that are less likely to reach the sentinel cage 79

80 Sentinel testing 1. Proven to detect many prevalent pathogens 2. Soiled bedding transfer easy to implement 3. Survey many cages for pathogens 4. Misses pathogens not transmitted in bedding 5. Positive results = disease present for many weeks 1. Best accuracy Sentinel testing 2. May not have access to colony animals 3. Run more test to screen all colonies : high cost Environmental monitoring 1. Survey many cages for pathogens 2. Accuracy dependent on sample location ( cage vs rack vs room) 3. Cannot detect pathogens that are not shed 80

81 Optimize your health monitoring program Optimal quarterly health monitoring requires a combination of samples from sentinels, colony animals and environment? 81

82 «Success is the sum of small efforts repeated day in and day out» Robert Collier Questions? 82

STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA

STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA SOP#: 410.16 Date Issued: 1/00 Date Revised: 10/17 Page 1of 7 TITLE: SCOPE: RESPONSIBILITY: PURPOSE: All Animal

More information

Health monitoring. Research Models and Services. Serology. The Envigo advantage

Health monitoring. Research Models and Services. Serology. The Envigo advantage Research Models and Services Health monitoring The disease status of laboratory animals has improved significantly over the last 25 years. This has resulted in the increased availability of animals free

More information

RODENT COLONY HEALTH MONITORING

RODENT COLONY HEALTH MONITORING 1 Washington State University Institutional Animal Care and Use Committee RODENT COLONY HEALTH MONITORING A. Purpose and Responsibility 1. The purpose of the rodent health monitoring program is to evaluate

More information

University Animal Care Committee (UACC) Standard Operating Procedure (SOP) Rodent Health Surveillance Program

University Animal Care Committee (UACC) Standard Operating Procedure (SOP) Rodent Health Surveillance Program Institutional SOP M0: Rodent Health Surveillance University Animal Care Committee (UACC) Standard Operating Procedure (SOP) SOP # M0 Title Rodent Health Surveillance Program. Purpose This Standard Operating

More information

Diagnostic Summary Report

Diagnostic Summary Report 3801 University Street 8th Floor Animal Facility Montreal, QC H3A 2B4 Canada Diagnostic Summary Report Approved: Bill Method: 25 Apr 2013, 09:07 PO# P0377426 Attn: Dr. Jessica Hutta housing rms fecal,

More information

i) Wild animals: Those animals that do not live under human supervision or control and do not have their phenotype selected by humans.

i) Wild animals: Those animals that do not live under human supervision or control and do not have their phenotype selected by humans. The OIE Validation Recommendations provide detailed information and examples in support of the OIE Validation Standard that is published as Chapter 1.1.6 of the Terrestrial Manual, or Chapter 1.1.2 of

More information

Step-by-Step Description of ELISA

Step-by-Step Description of ELISA Step-by-Step Description of ELISA The protocols in this kit rely on indirect antibody capture ELISA. The steps in this assay are: Step 1: Antigen is added to the wells of the microplate strip and incubated

More information

A Novel Biosecurity Auditing Process for Laboratory Rodent Facilities

A Novel Biosecurity Auditing Process for Laboratory Rodent Facilities A Novel Biosecurity Auditing Process for Laboratory Rodent Facilities William Porter, Mandy Horn, Hilton Klein AALAS District 5 Meeting Indianapolis, IN May 10, 2012 Introduction What is Biosecurity? Why

More information

Part 1 Johne s Disease Overview A concise summary of the latest facts about Johne s disease and recommended methods for diagnosis and control.

Part 1 Johne s Disease Overview A concise summary of the latest facts about Johne s disease and recommended methods for diagnosis and control. Johne s Disease: Practical Solutions and Problem Solving Michael T. Collins, DVM, PhD, DACVM, Professor School of Veterinary Medicine University of Wisconsin Madison, WI 53706 Part 1 Johne s Disease Overview

More information

Laboratory Research Ethics, Conduct and Safety

Laboratory Research Ethics, Conduct and Safety Laboratory Research Ethics, Conduct and Safety Biohazards and Biosafety Guidelines & Standards Human Pathogens Public Health Agency of Canada Canadian Food Inspection Agency Animal Pathogens Definition:

More information

Microbiological Quality: Understanding Drinking Water Quality and Management

Microbiological Quality: Understanding Drinking Water Quality and Management S A S K A T C H E W A N Microbiological Quality: Understanding Drinking Water Quality and Management June 2017 EPB 197 Table of Contents Page Number How to Determine the Microbiological Quality... 1 Monitoring

More information

QUALITY CONTROL/QUALITY ASSURANCE IN THE MOLECULAR MICROBIOLOGY LABORATORY

QUALITY CONTROL/QUALITY ASSURANCE IN THE MOLECULAR MICROBIOLOGY LABORATORY QUALITY CONTROL/QUALITY ASSURANCE IN THE MOLECULAR MICROBIOLOGY LABORATORY Richard L. Hodinka, Ph.D. University of South Carolina School of Medicine Greenville Greenville Health System, Greenville, SC

More information

Biosecurity for Aquaculture Facilities. Biosecurity. Use of Biosecurity. Practices, procedures and policies to prevent introduction and spread

Biosecurity for Aquaculture Facilities. Biosecurity. Use of Biosecurity. Practices, procedures and policies to prevent introduction and spread Biosecurity for Aquaculture Facilities Biosecurity Practices, procedures and policies to prevent introduction and spread Infectious diseases Microorganisms Bacteria, viruses, fungi Parasites Aquatic invasive

More information

ABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18

ABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18 M26-A ISBN 1-56238-384-1 September 1999 ISSN 0273-3099 Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline Volume 19 Number 18 Arthur L. Barry, Ph.D. William A. Craig,

More information

Biosafety Level 2 (BSL-2) Laboratory Guidelines

Biosafety Level 2 (BSL-2) Laboratory Guidelines Biosafety Level 2 (BSL-2) Laboratory Guidelines Table of Contents 1. Introduction... 2 2. Required Document for BUA Application Process... 2 3. Training... 2 4. Signage... 2 5. Transporting Biohazardous

More information

Vertebrate Animal Use Protocol for Research or Testing

Vertebrate Animal Use Protocol for Research or Testing AUP #: ORC USE ONLY Vertebrate Animal Use Protocol for Research or Testing Date Received: Instructions and Researcher Certifications (Failure to follow may result in a delay in processing) Complete this

More information

Virginia Western Community College BIO 205 General Microbiology

Virginia Western Community College BIO 205 General Microbiology Prerequisites BIO 205 General Microbiology One year of college biology and one year of college chemistry or divisional approval; an ENG 111 placement recommendation, co-enrollment in ENF 3/ENG 111, or

More information

Safe Operating Procedure

Safe Operating Procedure Safe Operating Procedure RECOMBINANT OR SYNTHETIC NUCLEIC ACIDS IBC AND OTHER REVIEW REQUIREMENTS (For assistance, please contact EHS at (402) 472-4925, or visit our web site at http://ehs.unl.edu/) (Revised

More information

BIOSAFETY GUIDELINES BACKGROUND ON BIOSAFETY

BIOSAFETY GUIDELINES BACKGROUND ON BIOSAFETY BIOSAFETY GUIDELINES BACKGROUND ON BIOSAFETY In addition to following general laboratory safety rules, additional rules must be implemented in the microbiology lab since students are working with living

More information

Microbiological monitoring of laboratory mice and biocontainment in individually ventilated cages: a field study

Microbiological monitoring of laboratory mice and biocontainment in individually ventilated cages: a field study Microbiological monitoring of laboratory mice and biocontainment in individually ventilated cages: a field study M Brielmeier 1, E Mahabir 1, J R Needham 2, C Lengger 3, P Wilhelm 1 and J Schmidt 1 1 Department

More information

Inspection Checklist for NIH BL3 Laboratories (7 CFR 331; 9 CFR 121; 42 CFR 73; NIH Guidelines)

Inspection Checklist for NIH BL3 Laboratories (7 CFR 331; 9 CFR 121; 42 CFR 73; NIH Guidelines) 12(a) 12(a) 12(b) 12 (c)(3) An individual or entity required to register under this part must develop and implement a written biosafety plan that is commensurate with the risk of the agent or toxin, given

More information

BIOPHARMACEUTICAL PROCESS EVALUATED FOR VIRAL CLEARANCE

BIOPHARMACEUTICAL PROCESS EVALUATED FOR VIRAL CLEARANCE The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate and/or remove potential viral contaminants. Experience and knowledge in selecting

More information

BIOHAZARD RISK ASSESSMENT

BIOHAZARD RISK ASSESSMENT BIOHAZARD RISK ASSESSMENT NAME: DATE: TITLE OF ACTIVITY OR PROJECT: BRIEF DESCRIPTION OF THE BIOLOGICAL AND ITS TREATMENT: DURATION OF ACTIVITY OR PROJECT: FACILITY TO BE USED (Campus, Building and Room

More information

Policies Concerning Survival Surgery of Mice

Policies Concerning Survival Surgery of Mice Policies Concerning Survival Surgery of Mice Date approved: October 25, 2016 Purpose This document details the minimum standards for survival (recovery) surgery in all laboratory rodent species. Responsibility

More information

MICROBIO, IMMUN, PATHOLOGY-MIP (MIP)

MICROBIO, IMMUN, PATHOLOGY-MIP (MIP) Microbio, Immun, Pathology-MIP (MIP) 1 MICROBIO, IMMUN, PATHOLOGY-MIP (MIP) Courses MIP 101 Introduction to Human Disease (GT-SC2) Credits: 3 (3-0-0) Survey of human systems and diseases. Additional Information:

More information

Sterilization & Disinfection

Sterilization & Disinfection Sterilization & Disinfection Prof. Hanan Habib College of Medicine-KSU Objectives 1- Define the terms sterilization, disinfectant and antiseptic. 2- Classify the different methods of sterilization (physical

More information

Update on the IVDR. Sue Spencer

Update on the IVDR. Sue Spencer Update on the IVDR Sue Spencer Caution The new regulations are draft the principles have now been agreed but the Annexes are subject to minor changes Further details will be added later pre and post application

More information

Laboratory Risk Assessment Form. PART A: Research/Investigation. Principal Investigator: Department: Location of Research: Funding agency: Agent Used:

Laboratory Risk Assessment Form. PART A: Research/Investigation. Principal Investigator: Department: Location of Research: Funding agency: Agent Used: Laboratory Risk Assessment Form PART A: Research/Investigation Principal Investigator: Department: Location of Research: Funding agency: Agent Used: Material Safety Data Sheet (MSDS) available? Risk Group

More information

transport of biological materials

transport of biological materials UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO STANDARD OPERATING PROCEDURE transport of biological materials Prepared by Date Adopted Procedure # IBC Approved EHS B001 May 13, 2014 ENVIRONMENTAL

More information

Version 9/12/2016 Page 1 of 10

Version 9/12/2016 Page 1 of 10 Instructions for the Application for Teaching Activities Involving Biohazardous Agents (NIH Recombinant and Synthetic Nucleic Acid Molecules, Other Biohazardous Agents, and Human Materials) The Application

More information

IBC protocol Risk Assessment and Determination of NIH Guidelines

IBC protocol Risk Assessment and Determination of NIH Guidelines IBC protocol Risk Assessment and Determination of NIH Guidelines The following are points to consider when reviewing all protocols for risk, recommended containment conditions, and determine applicable

More information

Hepatitis A Virus genesig Easy Kit for use on the genesig q16

Hepatitis A Virus genesig Easy Kit for use on the genesig q16 TM Primerdesign Ltd genesig Easy Kit for use on the genesig q16 50 reaction For general laboratory and research use only 1 genesig Easy: at a glance guide For each RNA test Component Volume HAV primer/probe

More information

The definitions given below have been selected and restricted to those that are likely to be useful to users of this OIE Terrestrial Manual.

The definitions given below have been selected and restricted to those that are likely to be useful to users of this OIE Terrestrial Manual. The definitions given below have been selected and restricted to those that are likely to be useful to users of this OIE Terrestrial Manual. Absorbance, also termed optical density (OD), describes the

More information

CLIA Complexity: MODERATE

CLIA Complexity: MODERATE CLIA Complexity: MODERATE INTENDED USE The is intended for the rapid detection of Group A Streptococcal antigen directly from throat swabs and beta-hemolytic colonies recovered from culture. This test

More information

Product# TM Intended Use. use only and not for use in diagnostic procedures.

Product# TM Intended Use. use only and not for use in diagnostic procedures. 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com Norovirus TaqMan RT-PCR Kit Product# TM41400 Product Insert Intended

More information

Application of Quality Risk Management Tools for Cell Therapy Manufacturing

Application of Quality Risk Management Tools for Cell Therapy Manufacturing Application of Quality Risk Management Tools for Cell Therapy Manufacturing 17 th ISCT Annual Meeting May 20, 2011 Jean Stanton Associate Director, Product Quality Management Janssen Supply Chain Conflict/Disclaimer

More information

Assessment of Torque Teno Virus as a Viral Pathogen Indicator in Waters [Project #4288]

Assessment of Torque Teno Virus as a Viral Pathogen Indicator in Waters [Project #4288] Assessment of Torque Teno Virus as a Viral Pathogen Indicator in Waters [Project #4288] ORDER NUMBER: 4288 DATE AVAILABLE: July 2013 PRINCIPAL INVESTIGATORS: Jeanine D. Plummer and Sharon C. Long For the

More information

Mice as Translational Models: Planning a Fecal Microbiota Transplantation Study

Mice as Translational Models: Planning a Fecal Microbiota Transplantation Study Mice as Translational Models: Planning a Fecal Microbiota Transplantation Study RANDI LUNDBERG, DVM APPLICATIONS SCIENTIST 3 rd Annual Translational Microbiome Conference Boston, April 11-13, 2017 FMT

More information

GUIDELINES FOR SHIPPING NONPATHOGENIC BIOLOGICAL CULTURES AND NON-INFECTIOUS BIOLOGICAL MATERIALS

GUIDELINES FOR SHIPPING NONPATHOGENIC BIOLOGICAL CULTURES AND NON-INFECTIOUS BIOLOGICAL MATERIALS GUIDELINES FOR SHIPPING NONPATHOGENIC BIOLOGICAL CULTURES AND NON-INFECTIOUS BIOLOGICAL MATERIALS Table of Contents General Information Regulations Definitions Recommended packing procedure Universal precautions

More information

Classification under the IVD Regulation

Classification under the IVD Regulation Classification under the IVD Regulation Nick Baker Head of IVD Notified Body LRQA Ltd Improving performance, reducing risk IVD regulation shift in regulatory scrutiny Under the current IVD directive 10-15%

More information

GMO Technology Conference

GMO Technology Conference GMO Technology Conference The regulation of Clinical Trials on humans involving therapies containing or consisting of genetically modified organisms The Printworks, Dublin Castle 10 th & 11 th October

More information

BIO 205 Microbiology with Lab (Title Change ONLY Oct. 2013) Course Package. Approved December 10, 2004 Effective Spring 2005

BIO 205 Microbiology with Lab (Title Change ONLY Oct. 2013) Course Package. Approved December 10, 2004 Effective Spring 2005 BIO 205 Microbiology with Lab (Title Change ONLY Oct. 2013) Course Package Approved December 10, 2004 Effective Spring 2005 Modified April 3, 2009 COURSE INFORMATION Title MICROBIOLOGY Number BIO 205 Catalog

More information

E. coli O26 Latex Test Kit

E. coli O26 Latex Test Kit Importance of STEC Determination Shiga toxin-producing Escherichia coli strains (non-o157 STEC) have become an increasing public health concern. Some of the non-o157 STEC possess the same range of virulence

More information

PIP ALLERGY FREE MICROBIOLOGICAL VALIDATION

PIP ALLERGY FREE MICROBIOLOGICAL VALIDATION PROJECT REPORT August 2007 PIP ALLERGY FREE MICROBIOLOGICAL VALIDATION Partners Chrisal N.V. Lommel (Producer/Project responsible) Universiteit Gent Gent (Microbiological analyses) Avecom N.V. Gent (Consultancy

More information

Animal Issues in Research Reproducibility

Animal Issues in Research Reproducibility Animal Issues in Research Reproducibility Gaylen L. Edwards, DVM, PhD Animal Care and Experimentation Committee American Physiological Society College of Veterinary Medicine University of Georgia Why Should

More information

Biosafety Protocol. Biodesign Swette Center for Environmental Biotechnology Standard Operating Procedures

Biosafety Protocol. Biodesign Swette Center for Environmental Biotechnology Standard Operating Procedures Biosafety Protocol Written by: Diane Hagner 11-4-15 Updated: Sarah Arrowsmith 2-28-17 1 P a g e Purpose The Biodesign Institute Center for Environmental Biotechnology Biosafety Protocol is intended to

More information

BIOSAFETY AND BIOSECURITY (BSS) Series Catalog

BIOSAFETY AND BIOSECURITY (BSS) Series Catalog BIOSAFETY AND BIOSECURITY (BSS) Series Catalog CITI Program s BSS series consists of courses that cover a variety of biosafety and biosecurity topics. These courses address basic information for multiple

More information

SAMPLE. NCFE Level 2. Certificate in the Principles of the Prevention and Control of Infection in Health Care Settings. Part A

SAMPLE. NCFE Level 2. Certificate in the Principles of the Prevention and Control of Infection in Health Care Settings. Part A Level 2 Certificate in the Prevention and Control of Infection Introduction NCFE Level 2 Certificate in the Principles of the Prevention and Control of Infection in Health Care Settings 1 Part A These

More information

Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services

Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations Audrey Chang, PhD, Senior Director Development Services Definition of Biologics: PHS Act, section 351 Virus, therapeutic

More information

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,

More information

VHP Sterilization and Prion Inactivation

VHP Sterilization and Prion Inactivation WFHSS Workshop Opatija Croatia March 27 th 2009 VHP Sterilization and Prion Inactivation Dr. Georgia Alevizopoulou Clinical Specialist Eastern Europe, Middle East & Africa VHP Sterilization and Prion Inactivation

More information

Standard Microbiological Practices

Standard Microbiological Practices Standard Microbiological Practices UT Biosafety Office http://biosafety.utk.edu Standard Microbiological Practices (SMP) What are they? Basic hygiene practices that apply to all labs and clinics that manipulate

More information

PARTIALLY PURIFIED LENTINAN FROM SHIITAKE MUSHROOM (LENTINUS EDODES) STILL RETAIN ANTITUMOUR ACTIVITY

PARTIALLY PURIFIED LENTINAN FROM SHIITAKE MUSHROOM (LENTINUS EDODES) STILL RETAIN ANTITUMOUR ACTIVITY -------The 3 rd ICMBMP October 1999 PARTIALLY PURIFIED LENTINAN FROM SHIITAKE MUSHROOM (LENTINUS EDODES) STILL RETAIN ANTITUMOUR ACTIVITY Ann-Teck Yap, Sudhir Kumar Chandramohan, Mah-Lee Ng Mary Department

More information

Herpes Simplex Virus Type 1 (HSV-1) IgM ELISA Kit Protocol

Herpes Simplex Virus Type 1 (HSV-1) IgM ELISA Kit Protocol Herpes Simplex Virus Type 1 (HSV-1) IgM ELISA Kit Protocol (Cat. No.:EK-310-93) 330 Beach Road, Burlingame CA Tel: 650-558-8898 Fax: 650-558-1686 E-Mail: info@phoenixpeptide.com www.phoenixpeptide.com

More information

Use of Neonatal Fostering To Remove Helicobacter spp. from Deer Mice (Peromyscus maniculatus)

Use of Neonatal Fostering To Remove Helicobacter spp. from Deer Mice (Peromyscus maniculatus) Journal of the American Association for Laboratory Animal Science Copyright 2015 by the American Association for Laboratory Animal Science Vol 54, No 4 Pages 439 444 Use of Neonatal Fostering To Remove

More information

Departmental Exposure Control Plan

Departmental Exposure Control Plan Section 12 Safety Information Book Prevention of Exposure to Human-derived Chemicals that are Considered Potentially Infectious Human Materials Departmental Exposure Control Plan Departments: Biology,

More information

Training Bulletin. Emergency Health Services Branch Ministry of Health and Long-Term Care. October 24, Issue Number version 2.

Training Bulletin. Emergency Health Services Branch Ministry of Health and Long-Term Care. October 24, Issue Number version 2. Training Bulletin Ebola Virus Disease October 24, 2014 Issue Number 114 - version 2.1 Emergency Health Services Branch Ministry of Health and Long-Term Care Training Bulletin, Issue Number 114 version

More information

Microbial Growth and The Control of Microbial Growth (Chapter 6 & 7)

Microbial Growth and The Control of Microbial Growth (Chapter 6 & 7) Microbial Growth and The Control of Microbial Growth (Chapter 6 & 7) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Eastern Campus Primary Source for figures and content:

More information

Improving Murine Health Surveillance Programs with the Help of On-site Enzyme-linked Immunosorbent Assay

Improving Murine Health Surveillance Programs with the Help of On-site Enzyme-linked Immunosorbent Assay Journal of the American Association for Laboratory Animal Science Copyright 2006 by the American Association for Laboratory Animal Science Vol 45, No 4 Pages 24 28 Improving Murine Health Surveillance

More information

Antibody-based HLA (Human Leucocyte Antigen ) tissue-typing technologies

Antibody-based HLA (Human Leucocyte Antigen ) tissue-typing technologies Human AB Serum Product Description Human AB Serum is a vital cell culture reagent for some human cell types providing growth factors, vitamins, nutrients as well as trace elements and transport factors,

More information

Efficacy Report Summarization for SoClean 2

Efficacy Report Summarization for SoClean 2 Efficacy Report Summarization for SoClean 2 October 2017 SoClean Inc 36 Town Forest Road Oxford, Massachusetts 01540 USA Tel. 508-363-0418 Email info@soclean.com SoClean 2 is USA FDA Registered 3009534409

More information

Prevalence of Shiga-Toxin Producing Escherichia Coli in Two Cohorts of Beef Cattle is Associated with Diversity of Microflora and Animal Age

Prevalence of Shiga-Toxin Producing Escherichia Coli in Two Cohorts of Beef Cattle is Associated with Diversity of Microflora and Animal Age Prevalence of Shiga-Toxin Producing Escherichia Coli in Two Cohorts of Beef Cattle is Associated with Diversity of Microflora and Animal Age Raies A. Mir 1,2, Sarah M. Markland 1,2, Mauricio Elzo 1, Soohyoun

More information

Clonetics Skeletal Muscle Myoblast Cell Systems HSMM Instructions for Use

Clonetics Skeletal Muscle Myoblast Cell Systems HSMM Instructions for Use Lonza Walkersville, Inc. Walkersville, MD 21793-0127 USA U.S. Scientific Support: 800 521 0390 scientific.support@lonza.com EU/ROW Scientific Support: +32 87 321 611 scientific.support.eu@lonza.com Document

More information

Preparation thin blood films and Giemsa staining

Preparation thin blood films and Giemsa staining TLM_PRO_026 Version No.001 Page 1 of 5 Department: Clinical sciences Unit: Tropical Laboratory Medicine Preparation thin blood films and Giemsa staining Project/study: Not applicable 1. Scope and application

More information

AmoyDx JAK2 Mutation Detection Kit

AmoyDx JAK2 Mutation Detection Kit AmoyDx JAK2 Mutation Detection Kit Detection of V617F mutation in the JAK2 oncogene Instructions For Use For Research Use Only and For Reference Only Instructions Version: B1.2 Date of Revision: June 2016

More information

The New Choice in Disinfection Technology

The New Choice in Disinfection Technology The New Choice in Disinfection Technology www.contecinc.com Introducing The New Choice in Disinfection Technology Accel TB Is A Powerful Disinfectant Against: VIRUCIDAL: 1 Min. at 20 C Proven effectiveness

More information

Name Block Desk # BACTERIA AND VIRUSES. 1. What are prokaryotes? They are -celled organisms with no

Name Block Desk # BACTERIA AND VIRUSES. 1. What are prokaryotes? They are -celled organisms with no Name Block Desk # BACTERIA AND VIRUSES Identifying Bacteria: 1. What are prokaryotes? They are -celled organisms with no - bound organelles. 2. True or false: prokaryotes are much larger that eukaryotes.

More information

MICROBIOLOGICAL ANALYSIS OF FOOD & FOOD PRODUCTS

MICROBIOLOGICAL ANALYSIS OF FOOD & FOOD PRODUCTS MICROBIOLOGICAL ANALYSIS OF FOOD & FOOD PRODUCTS By Angshuman Saha Assistant Director Export Inspection Agency-Mumbai, PTH & T Maheswara Rao Technical Officer Export Inspection Agency-Mumbai, PTH 1 Introduction

More information

Mycobacterium tuberculosis End-Point PCR Kit Product# EP42100

Mycobacterium tuberculosis End-Point PCR Kit Product# EP42100 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com Mycobacterium tuberculosis End-Point PCR Kit Product# EP42100

More information

Module 2: GAPs Field Practices

Module 2: GAPs Field Practices Module 2: GAPs Field Practices Dr. Chris Gunter, Assistant Professor, N.C. State University, Department of Horticultural Science, Vegetable Production Billy Little, Commercial Horticulture, Wilson Cooperative

More information

3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: (905) Fax: (905)

3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: (905) Fax: (905) 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com E.coli O157:H7 End-Point PCR Kit Product# EP41300 Product Insert

More information

Adding CRISPR to Your Bio-ARROW Protocol

Adding CRISPR to Your Bio-ARROW Protocol Adding CRISPR to Your Bio-ARROW Protocol Table of Contents Work Covered by this Guidance Document... 2 Background... 2 VI. Materials and Activities... 3 VI. Materials and Activities - Recombinant Materials...

More information

Lab Exercise #4 Microbial Control Lab Exercise #4 Control of Microorganisms: Physical, Chemical and Chemotherapeutic

Lab Exercise #4 Microbial Control Lab Exercise #4 Control of Microorganisms: Physical, Chemical and Chemotherapeutic Lab Exercise #4 Control of Microorganisms: Physical, Chemical and Chemotherapeutic I. OBJECTIVES: Investigate the effectiveness various agents of control. Assess the effectiveness of heat in killing vegetative

More information

Course Descriptions. BIOL: Biology. MICB: Microbiology. [1]

Course Descriptions. BIOL: Biology. MICB: Microbiology.  [1] Course Descriptions BIOL: Biology http://www.calendar.ubc.ca/vancouver/courses.cfm?code=biol [1] BIOL 112 (3) Biology of the Cell The principles of cellular and molecular biology using bacterial and eukaryotic

More information

Patentability/Literature Research

Patentability/Literature Research Patentability/Literature Research The probiotic-based solution to combat cholera as presented here comprises of two major innovative components: (1) the metabolite-dependent pathogen inhibition by a probiotic

More information

Bill Kabat and Carmen Irizarry of the ACTG/IMPAACT Lab Tech Committee. Network Name, Title Signature Date

Bill Kabat and Carmen Irizarry of the ACTG/IMPAACT Lab Tech Committee. Network Name, Title Signature Date Title: Dried PBMC Pellet Processing Standard Operating Procedure (LDMS specimen code = BLD/EDTA or ACD/PEL) Origination Date: 01 Jun 2004 Total Pages: 6 Effective Date: 29 Nov 2012 SOP Number LTC-SOP-59

More information

State-of-the-art, ultra-high density BashingBeads are fracture resistant and chemically inert.

State-of-the-art, ultra-high density BashingBeads are fracture resistant and chemically inert. INSTRUCTION MANUAL Quick-DNA Fecal/Soil Microbe Miniprep Kit Catalog No. D6010 Highlights Rapid method for the isolation of inhibitor-free, PCR-quality DNA (up to 25 µg/prep) from microbes including Gram-positive

More information

Prevention of Transmission of the Superbug Carbapenem-Resistant Enterobacteriaceae (CRE) during Gastrointestinal Endoscopy

Prevention of Transmission of the Superbug Carbapenem-Resistant Enterobacteriaceae (CRE) during Gastrointestinal Endoscopy Prevention of Transmission of the Superbug Carbapenem-Resistant Enterobacteriaceae (CRE) during Gastrointestinal Endoscopy Sponsored by: Presentation by: Lawrence F. Muscarella, Ph.D. President LFM Healthcare

More information

Office of Graduate and Professional Studies

Office of Graduate and Professional Studies Reset Form Print Form Office of Graduate and Professional Studies PROPOSAL APPROVAL FORM FOR THESIS, DISSERTATION, OR RECORD OF STUDY Full proposal should be attached This form must be approved by OGAPS

More information

Use of Gene Editing Technologies in Rodents. Carlisle P. Landel, Ph.D.

Use of Gene Editing Technologies in Rodents. Carlisle P. Landel, Ph.D. Use of Gene Editing Technologies in Rodents Carlisle P. Landel, Ph.D. The Mouse as A Model Mammal Small, easy to maintain, fecund Well understood genetics Similarity to humans >90% Availability of inbred

More information

SAFETY MANUAL OF GOOD LABORATORY

SAFETY MANUAL OF GOOD LABORATORY SAFETY MANUAL OF GOOD LABORATORY PRACTICES 1 THE LABORATORY The biotechnology laboratory platform is an area where many risks are present. In it we use different products and agents that may be harmful

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Department of Microbiology 3 rd Floor Darent Valley Hospital Darenth Wood Road Dartford DA2 8DA United Kingdom Contact: Mr Kurt Djemal Tel: +44 (0) 1322 428733 E-Mail: k.djemal@nhs.net Website: http://www.dvh.nhs.uk/

More information

PRINCIPLES AND GUIDELINES FOR THE CONDUCT OF MICROBIOLOGICAL RISK ASSESSMENT CAC/GL Adopted Amendments 2012, 2014.

PRINCIPLES AND GUIDELINES FOR THE CONDUCT OF MICROBIOLOGICAL RISK ASSESSMENT CAC/GL Adopted Amendments 2012, 2014. PRINCIPLES AND GUIDELINES FOR THE CONDUCT OF MICROBIOLOGICAL RISK ASSESSMENT CAC/GL 30-1999 Adopted 1999. Amendments 2012, 2014. CAC/GL 30-1999 2 1. INTRODUCTION 2. SCOPE 3. DEFINITIONS 4. GENERAL PRINCIPLES

More information

A. Incorrect! The study of Microorganisms is included in the definition of microbiology.

A. Incorrect! The study of Microorganisms is included in the definition of microbiology. Microbiology - Problem Drill 01: Introduction to Microbiology No. 1 of 10 1. Microbiology is the study of all of the following except. (A) Microorganisms (B) Viruses (C) Multicellular parasites (D) Plants

More information

HIGH SCHOOL STUDENT SCIENCE WEEK. St. Paul s Hospital Vancouver, BC

HIGH SCHOOL STUDENT SCIENCE WEEK. St. Paul s Hospital Vancouver, BC HIGH SCHOOL STUDENT SCIENCE WEEK St. Paul s Hospital Vancouver, BC Sponsors 2 AGENDA Location: UBC James Hogg Research Centre (JHRC), St. Paul s Hospital, Room 166 Burrard Building, 1081 Burrard Street,

More information

Biosafety Manual 2016

Biosafety Manual 2016 2016 Policy Statement It is the policy of Northern Arizona University (NAU) to provide a safe working environment. The primary responsibility for insuring safe conduct and conditions in the laboratory

More information

Laboratory Safety. Marlia Singgih Wibowo School of Pharmacy ITB

Laboratory Safety. Marlia Singgih Wibowo School of Pharmacy ITB Laboratory Safety Marlia Singgih Wibowo School of Pharmacy ITB Topics in Laboratory Safety Risk evaluation : pharmaceutical consideration, mikrobiological consideration, risk quantification, risk management

More information

6/28/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics

6/28/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics Control of Microbial Growth Disinfectants and Antiseptics 1 Method Three approaches for the control of microbial growth Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical

More information

Selection and use of Ebola in vitro diagnostic (IVD) assays

Selection and use of Ebola in vitro diagnostic (IVD) assays EMERGENCY GUIDANCE Selection and use of Ebola in vitro diagnostic (IVD) assays June 2015 World Health Organization 2015. All rights reserved. The designations employed and the presentation of the material

More information

OIE Guideline. International Reference Antibody Standards for Antibody Assays. 1. Introduction

OIE Guideline. International Reference Antibody Standards for Antibody Assays. 1. Introduction OIE Guideline International Reference Antibody Standards for Antibody Assays 1. Introduction 1.1. Purpose This document provides guidelines for the preparation, validation and distribution of antibodies

More information

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

USP Chapter 823 USP 32 (old) vs. USP 35 (new) USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has

More information

Risk Determination of Human Biological Material Guidelines (HS651)

Risk Determination of Human Biological Material Guidelines (HS651) Risk Determination of Human Biological Material Guidelines (HS651) Policy Hierarchy link Work Health and Safety Policy HS323 Biosafety Procedure Responsible Officer Director, UNSW Safety and Sustainability

More information

IgG Antibodies To Toxoplasma. Gondii ELISA Kit

IgG Antibodies To Toxoplasma. Gondii ELISA Kit IgG Antibodies To Toxoplasma Catalog No: IRAPKT1405 Gondii ELISA Kit Lot No: SAMPLE INTENDED USE The Toxoplasma IgG ELISA is intended for use in evaluating a patient s serologic status to Toxoplasma gondii

More information

Water Pollution & Quality. Dr. Deniz AKGÜL Marmara University Department of Environmental Engineering

Water Pollution & Quality. Dr. Deniz AKGÜL Marmara University Department of Environmental Engineering Water Pollution & Quality Dr. Deniz AKGÜL Marmara University Department of Environmental Engineering IMPORTANCE OF WATER Life on planet Earth would be impossible without water. All life forms, from simple

More information

PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec)

PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec) PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec) INDICATION IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable

More information

Protocol for Albuwell M kit: Murine Microalbuminuria ELISA By Exocell Inc

Protocol for Albuwell M kit: Murine Microalbuminuria ELISA By Exocell Inc Version: 1.1 Replaced by version: 1.0 Edited by: Kathi Burke (Frank Brosius Lab) Peter Reifsnyder (Ed Leiter Lab) Summary Reagents and Materials Protocol Protocol for Albuwell M kit: Murine Microalbuminuria

More information

CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS

CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS Specific control measures can be used to kill or inhibit the growth of microorganisms. A procedure which leads to the death of cells is broadly

More information

Product# EP Product Description

Product# EP Product Description 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com Chlamydia End-Point PCR Kit Product# EP31400 Product Insert Intended

More information